Skip to content

Absci Corporation ABSI Contract Liabilities

Contract Liabilities at other companies

Schrodinger logo
SchrodingerSDGR
$59.02M-43.5%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$114.72M-11.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$8.99M-72.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$11.78M
Zymeworks logo
ZymeworksZYME
$14.61M0.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$8.83M

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's contract liabilities?
Absci Corporation (ABSI) reported contract liabilities of $641K in Q1 2026.
How has Absci Corporation's contract liabilities changed year-over-year?
Absci Corporation's contract liabilities decreased by 41.7% year-over-year, from $1.1M to $641K.
What does contract liabilities mean?
Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.